Medicare does cover Onureg, almost always through a Part D prescription drug plan, and in 2026 a beneficiary’s total out-of-pocket cost for the year is capped at $2,100 no matter how many cycles are filled.1NCOA. Who Pays What for Medicare Part D in 2026 That cap matters, because the retail price of a single 28-day cycle runs about $28,606.2GoodRx. Onureg Prices and Coupons
Part D Is the Usual Path
Onureg (oral azacitidine) is dispensed through specialty pharmacies and generally processed through Medicare Part D.3BMS Access Support. Onureg Codes and Coverage There is a Part B oral chemotherapy rule that covers certain oral drugs when they share an active ingredient and indication with a Part B injectable.4CMS. Oral Anticancer Drugs Injectable azacitidine (Vidaza) is a Part B drug, but it is used primarily for myelodysplastic syndromes while Onureg is approved only for AML maintenance, and the two are not interchangeable. Confirm with your pharmacist or plan which part of Medicare is paying before you fill the first prescription, since the cost-sharing rules differ.5OncoLink. Azacitidine Oral Formulation (Onureg)
What You’ll Actually Pay in 2026
Part D cost-sharing in 2026 runs in three phases:
- A deductible of up to $615, though some plans set it lower or waive it.6Medicare.gov. Medicare Part D Costs
- An initial coverage phase where you pay 25% of drug costs, the plan pays 65%, and the manufacturer pays 10%.1NCOA. Who Pays What for Medicare Part D in 2026
- Catastrophic coverage once your out-of-pocket spending reaches $2,100, after which you pay $0 for covered drugs for the rest of the year.6Medicare.gov. Medicare Part D Costs
At Onureg’s price, a single fill blows past the deductible and the 25% phase and lands you in catastrophic coverage immediately. For most beneficiaries, that means the full-year obligation is the $2,100 cap, not a percentage of the drug’s retail cost.
Spreading the $2,100 Across the Year
If paying $2,100 in January at the pharmacy counter is a problem, the Medicare Prescription Payment Plan lets you spread that bill into monthly installments across the calendar year.7Medicare.gov. Medicare Prescription Payment Plan Every Part D plan and every Medicare Advantage plan with drug coverage must offer it.8CMS. Medicare Prescription Payment Plan There are no fees and no interest. If you enroll in January and your out-of-pocket costs reach the full $2,100, you’d pay roughly $175 a month.9MedicareResources.org. How Will the Inflation Reduction Act Affect Medicare Enrollees The total you owe is the same; only the timing changes. Enrollment is voluntary, through your plan.
Prior Authorization and Appeals
Expect your plan to require prior authorization. For drugs that cost more than $10,000 for a 30-day supply, over 90% of Part D plans impose some form of utilization management, such as prior authorization, step therapy, or quantity limits.10National Library of Medicine. Utilization Management for Newly Approved Drugs in Medicare Part D BMS Access Support offers a plan-lookup tool called the BMS Access Map so prescribers can see what a specific plan needs.3BMS Access Support. Onureg Codes and Coverage
If coverage is denied, you have the right to appeal. Plans must decide standard exception requests within 72 hours and expedited requests within 24 hours.11BMS Access Support. Exceptions and Appeals Guide Part D has five levels of appeal, and your prescriber can file an exception request on your behalf with a letter of medical necessity.12Medicare.gov. Medicare Part D Plan Rules
A Note on Off-Label Use
Onureg is FDA-approved only for AML maintenance after first remission. Medicare plan policies typically require that use be supported by the FDA label, CMS-approved compendia, NCCN guidelines, ASCO guidelines, or qualifying peer-reviewed literature.13Neighborhood Health Plan of Rhode Island. Onureg Utilization Management Policy Plans generally will not cover Onureg as a substitute for injectable azacitidine in myelodysplastic syndromes, and the FDA label itself warns against that substitution outside a clinical trial.14Bristol Myers Squibb. FDA Approves Onureg (Azacitidine Tablets) for Adults in First Remission With AML
Help Covering What Medicare Doesn’t
Several programs can cut your $2,100 obligation further or absorb it entirely.
Medicare Extra Help
If your income and resources are limited, Medicare’s Extra Help (Low-Income Subsidy) program can nearly eliminate what you pay for Onureg. In 2026, Extra Help enrollees pay no more than $12.65 per brand-name prescription, dropping to $4.90 for those with Medicaid whose income is below the poverty level. The program also wipes out the Part D deductible and any late enrollment penalty. For 2026, income limits are $23,940 for individuals and $32,460 for married couples, with resource limits of $18,090 and $36,100.15MedicareResources.org. How Do I Qualify for Medicare’s Extra Help Program If you have full Medicaid, Supplemental Security Income, or participate in a Medicare Savings Program, enrollment is automatic.
HealthWell Foundation
HealthWell’s AML fund explicitly covers Onureg and offers grants of up to $10,000 to insured patients, including Medicare beneficiaries, with household incomes at or below 500% of the federal poverty level.16HealthWell Foundation. Acute Myeloid Leukemia Fund The average patient uses about $2,200 over 12 months, which lines up neatly with the Part D cap. Fund availability changes, so check before applying.
PAN Foundation
The Patient Access Network Foundation’s AML copay fund offers an initial grant of $2,200 and up to $4,400 per year. Eligibility requires government insurance (Medicare, Medicaid, or TRICARE) and household income at or below 500% of the federal poverty level. PAN is moving to a new platform called TotalAssist, with a portal at TotalAssist.org and a new line (866-512-3861) opening July 1, 2026.17PAN Foundation. Acute Myeloid Leukemia Fund The fund opens and closes with available funding, so expect a possible wait list.
Bristol Myers Squibb Patient Assistance Foundation
The BMS Patient Assistance Foundation is an independent charity that provides certain BMS medications, including Onureg, free of charge to eligible patients, with no application or delivery fees.18BMS Patient Assistance Foundation. BMSPAF It is generally geared toward uninsured patients in financial hardship. Full eligibility details are at the foundation’s site or by calling 1-800-736-0003.19Bristol Myers Squibb. Help Paying for Your Medicine
BMS Access Support
Bristol Myers Squibb also runs BMS Access Support, which helps providers and patients navigate coverage. It handles benefits investigations (often completed within 24 hours), prior authorization help, appeals support with template letters of medical necessity, and referrals to financial assistance for government-insured and uninsured patients.20BMS Access Support. Getting Started With BMS Access Support: An HCP Guide Providers can enroll patients through the MyBMSCases portal or by fax, or call 1-800-861-0048.21BMS Access Support. BMS Access Support